PHENELZINE SULFATE - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for phenelzine sulfate and what is the scope of patent protection?

Phenelzine sulfate is the generic ingredient in two branded drugs marketed by Parke Davis and Novel Labs Inc, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for phenelzine sulfate. Three suppliers are listed for this compound.

Summary for PHENELZINE SULFATE

US Patents:	0
Tradenames:	2
Applicants:	2
NDAs:	2
Drug Master File Entries:	4
Finished Product Suppliers / Packagers:	3
Raw Ingredient (Bulk) Api Vendors:	75
Clinical Trials:	4
Patent Applications:	3,057
Drug Prices:	Drug price trends for PHENELZINE SULFATE
What excipients (inactive ingredients) are in PHENELZINE SULFATE?	PHENELZINE SULFATE excipients list
DailyMed Link:	PHENELZINE SULFATE at DailyMed

See drug prices for PHENELZINE SULFATE

Recent Clinical Trials for PHENELZINE SULFATE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Boehringer Ingelheim	Phase 1
Liverpool Cancer Therapy Centre	Phase 1
The Canberra Hospital	Phase 1

See all PHENELZINE SULFATE clinical trials

Pharmacology for PHENELZINE SULFATE

Drug Class	Monoamine Oxidase Inhibitor
Mechanism of Action	Monoamine Oxidase Inhibitors

Medical Subject Heading (MeSH) Categories for PHENELZINE SULFATE

Antidepressive Agents
Monoamine Oxidase Inhibitors

Anatomical Therapeutic Chemical (ATC) Classes for PHENELZINE SULFATE

N06AF	Monoamine oxidase inhibitors, non-selective
N06A	ANTIDEPRESSANTS
N06	PSYCHOANALEPTICS
N	Nervous system

US Patents and Regulatory Information for PHENELZINE SULFATE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Novel Labs Inc	PHENELZINE SULFATE	phenelzine sulfate	TABLET;ORAL	200181-001	Dec 8, 2010	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Parke Davis	NARDIL	phenelzine sulfate	TABLET;ORAL	011909-002	Approved Prior to Jan 1, 1982	AB	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.